Skip to main content
Top
Literature
1.
go back to reference Punwani S, Taylor SA, Saad ZZ, Bainbridge A, Groves A, Daw S, et al. Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI? Eur J Nucl Med Mol Imaging. 2013;40:373–85.PubMedCrossRef Punwani S, Taylor SA, Saad ZZ, Bainbridge A, Groves A, Daw S, et al. Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI? Eur J Nucl Med Mol Imaging. 2013;40:373–85.PubMedCrossRef
2.
go back to reference Abdel Razek A, Soliman N, Elashery R. Apparent diffusion coefficient values of mediastinal masses in children. Eur J Radiol. 2012;81:1311–4.PubMedCrossRef Abdel Razek A, Soliman N, Elashery R. Apparent diffusion coefficient values of mediastinal masses in children. Eur J Radiol. 2012;81:1311–4.PubMedCrossRef
3.
go back to reference Abdel Razek A, Elmorsy A, Elshafey M, Elhadedy T, Hamza O. Assessment of mediastinal tumors with diffusion weighted single shot echo planar MR imaging. J Magn Reson Imaging. 2009;30:535–40.CrossRef Abdel Razek A, Elmorsy A, Elshafey M, Elhadedy T, Hamza O. Assessment of mediastinal tumors with diffusion weighted single shot echo planar MR imaging. J Magn Reson Imaging. 2009;30:535–40.CrossRef
4.
go back to reference Abdel Razek A, Elkammary S, Elmorsy A, Elshafey M, Elhadedy T. Characterization of mediastinal lymphadenopathy with diffusion-weighted imaging. Magn Reson Imaging. 2011;29:167–72.PubMedCrossRef Abdel Razek A, Elkammary S, Elmorsy A, Elshafey M, Elhadedy T. Characterization of mediastinal lymphadenopathy with diffusion-weighted imaging. Magn Reson Imaging. 2011;29:167–72.PubMedCrossRef
5.
go back to reference Padhani AR, Guoying L, Mu-Koh D, Chenevert TL, Thoeny HC, Takahara T, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia. 2009;11:102–25.PubMed Padhani AR, Guoying L, Mu-Koh D, Chenevert TL, Thoeny HC, Takahara T, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia. 2009;11:102–25.PubMed
6.
go back to reference Koh DM, Blackledge M, Padhani AR, Takahara T, Kwee TC, Leach MO, et al. Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls. AJR Am J Roentgenol. 2012;199:252–62.PubMedCrossRef Koh DM, Blackledge M, Padhani AR, Takahara T, Kwee TC, Leach MO, et al. Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls. AJR Am J Roentgenol. 2012;199:252–62.PubMedCrossRef
7.
go back to reference Lin C, Itti E, Luciani A, Haioun C, Meignan M, Rahmouni A. Whole-body diffusion-weighted imaging in lymphoma. Cancer Imaging. 2010;10:S172–8.PubMedCrossRef Lin C, Itti E, Luciani A, Haioun C, Meignan M, Rahmouni A. Whole-body diffusion-weighted imaging in lymphoma. Cancer Imaging. 2010;10:S172–8.PubMedCrossRef
8.
go back to reference Padhani AR, Koh DM, Collins DJ. Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. Radiology. 2011;261:700–18.PubMedCrossRef Padhani AR, Koh DM, Collins DJ. Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. Radiology. 2011;261:700–18.PubMedCrossRef
9.
go back to reference Dijstra H, Baron P, Kappert P, Oudkerk M, Sijens PE. Effects of microperfusion in hepatic diffusion weighted imaging. Eur Radiol. 2012;22:891–9.CrossRef Dijstra H, Baron P, Kappert P, Oudkerk M, Sijens PE. Effects of microperfusion in hepatic diffusion weighted imaging. Eur Radiol. 2012;22:891–9.CrossRef
10.
go back to reference Punwani S, Prakash V, Bainbridge A, Taylor SA, Bandula S, Olsen OE, et al. Quantitative diffusion weighted MRI: a functional biomarker of nodal disease in Hodgkin lymphoma? Cancer Biomark. 2010;7:249–59.PubMed Punwani S, Prakash V, Bainbridge A, Taylor SA, Bandula S, Olsen OE, et al. Quantitative diffusion weighted MRI: a functional biomarker of nodal disease in Hodgkin lymphoma? Cancer Biomark. 2010;7:249–59.PubMed
11.
go back to reference Spaepen K, Stroobants S, Verhoef G, Mortelmans L. Positron emission tomography with [(18)F]FDG for therapy response monitoring in lymphoma patients. Eur J Nucl Med Mol Imaging. 2003;30 Suppl 1:S97–105.PubMedCrossRef Spaepen K, Stroobants S, Verhoef G, Mortelmans L. Positron emission tomography with [(18)F]FDG for therapy response monitoring in lymphoma patients. Eur J Nucl Med Mol Imaging. 2003;30 Suppl 1:S97–105.PubMedCrossRef
Metadata
Title
Influence of selected b values on ADC quantification in diffusion-weighted MRI. Comment on Punwani et al.: Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI?
Authors
Adriano M. Priola
Sandro M. Priola
Publication date
01-07-2013
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 7/2013
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-013-2390-2

Other articles of this Issue 7/2013

European Journal of Nuclear Medicine and Molecular Imaging 7/2013 Go to the issue